NON-TRANSFUSION DEPENDENT THALASSEMIA
Clinical trials for NON-TRANSFUSION DEPENDENT THALASSEMIA explained in plain language.
Never miss a new study
Get alerted when new NON-TRANSFUSION DEPENDENT THALASSEMIA trials appear
Sign up with your email to follow new studies for NON-TRANSFUSION DEPENDENT THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for thalassemia: drug trial targets anemia without transfusions
Disease control Not yet recruitingThis study tests a new drug called SNH-119014 in 30 adults with a type of thalassemia that does not require regular blood transfusions. The goal is to see if the drug is safe and helps improve anemia. Participants will be monitored for side effects and how their body responds to …
Matched conditions: NON-TRANSFUSION DEPENDENT THALASSEMIA
Phase: PHASE2 • Sponsor: ScinnoHub Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Greek study to measure daily life impact of iron overload drug
Knowledge-focused Not yet recruitingThis study looks at how thalassemia patients in Greece feel day-to-day while taking a standard iron-removing medicine called deferasirox. Researchers will survey 150 adults to measure their physical and mental well-being. The goal is to understand real-world quality of life, not …
Matched conditions: NON-TRANSFUSION DEPENDENT THALASSEMIA
Sponsor: Elpen Pharmaceutical Co. Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC